[go: up one dir, main page]

BR112015012453A8 - métodos e usos para sincronizar o tempo de ovulação e de inseminação em uma leitoa - Google Patents

métodos e usos para sincronizar o tempo de ovulação e de inseminação em uma leitoa

Info

Publication number
BR112015012453A8
BR112015012453A8 BR112015012453A BR112015012453A BR112015012453A8 BR 112015012453 A8 BR112015012453 A8 BR 112015012453A8 BR 112015012453 A BR112015012453 A BR 112015012453A BR 112015012453 A BR112015012453 A BR 112015012453A BR 112015012453 A8 BR112015012453 A8 BR 112015012453A8
Authority
BR
Brazil
Prior art keywords
methods
gilt
insemination
synchronizing
synchronizing ovulation
Prior art date
Application number
BR112015012453A
Other languages
English (en)
Other versions
BR112015012453A2 (pt
Inventor
E Swanson Mark
e johnston Michael
R Kraeling Robert
Kent Webel Stephen
Original Assignee
Jbs United Animal Health Ii Llc
United Ah Ii Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jbs United Animal Health Ii Llc, United Ah Ii Llc filed Critical Jbs United Animal Health Ii Llc
Publication of BR112015012453A2 publication Critical patent/BR112015012453A2/pt
Publication of BR112015012453A8 publication Critical patent/BR112015012453A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/108—Swine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Environmental Sciences (AREA)
  • Synchronisation In Digital Transmission Systems (AREA)
  • Fodder In General (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

métodos e usos para sincronizar o tempo de ovulação e de inseminação em uma leitoa. métodos e composições para sincronizar o tempo de inseminação em leitoas são fornecidos. mais particularmente, métodos e composições para sincronizar o tempo de inseminação em leitoas usando um hormônio de liberação de gonadotrofina e um hormônio para sincronizar o ciclo estral são fornecidos.
BR112015012453A 2012-11-28 2013-11-27 métodos e usos para sincronizar o tempo de ovulação e de inseminação em uma leitoa BR112015012453A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261730763P 2012-11-28 2012-11-28
PCT/US2013/072359 WO2014085674A1 (en) 2012-11-28 2013-11-27 Method for synchronizing time of insemination in gilts

Publications (2)

Publication Number Publication Date
BR112015012453A2 BR112015012453A2 (pt) 2017-07-11
BR112015012453A8 true BR112015012453A8 (pt) 2021-06-29

Family

ID=50828486

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015012453A BR112015012453A8 (pt) 2012-11-28 2013-11-27 métodos e usos para sincronizar o tempo de ovulação e de inseminação em uma leitoa

Country Status (17)

Country Link
US (2) US9724380B2 (pt)
EP (1) EP2925339B1 (pt)
JP (1) JP2016508030A (pt)
KR (1) KR20150095715A (pt)
CN (2) CN104994865A (pt)
AU (1) AU2013352054A1 (pt)
BR (1) BR112015012453A8 (pt)
CA (1) CA2892762C (pt)
CL (1) CL2015001448A1 (pt)
CR (1) CR20150282A (pt)
DK (1) DK2925339T3 (pt)
ES (1) ES2808409T3 (pt)
MX (1) MX367876B (pt)
PH (1) PH12015501187A1 (pt)
RU (1) RU2015125549A (pt)
WO (1) WO2014085674A1 (pt)
ZA (1) ZA201504552B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005035717A2 (en) 2003-10-03 2005-04-21 Thorn Bioscience, Llc Process for the synchronization of ovulation for timed breeding without heat detection
CN102596215B (zh) 2009-04-23 2015-04-29 佩纳特克有限责任公司 用于同步授精时间的方法和组合物
ES2808409T3 (es) * 2012-11-28 2021-02-26 United Ah Ii Llc Método para sincronizar el tiempo de inseminación en cerdas primerizas
US20160375090A1 (en) * 2013-11-27 2016-12-29 Jbs United Animal Health Ii Llc Method and composition for synchronizing time of insemination in gilts
CN107173329A (zh) * 2017-07-07 2017-09-19 宣汉县蜀宣花牛养殖专业合作社 一种蜀宣花牛母牛繁殖方法
CN108853484B (zh) * 2018-07-23 2021-08-17 东北农业大学 一种诱导后备母猪同期发情的方法
CN115192693A (zh) * 2021-08-20 2022-10-18 北京市农林科学院 一种诱导母猪同期发情的方法
CN117981715B (zh) * 2024-04-07 2024-07-09 中国农业大学 一种促进后备母猪初情期启动和改善发情障碍的后备母猪批次化养殖方法

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3860701A (en) 1968-04-22 1975-01-14 Searle & Co Method for use and compositions of 11-lower alkyl steroids and drug delivery system for the controlled elution of 11-lower alkyl steroids
AT347054B (de) 1973-09-29 1978-12-11 Takeda Chemical Industries Ltd Verfahren zur herstellung von neuen nonapeptidamid-derivaten
US4005063A (en) 1973-10-11 1977-01-25 Abbott Laboratories [Des-gly]10 -GnRH nonapeptide anide analogs in position 6 having ovulation-inducing activity
US3991750A (en) 1975-04-28 1976-11-16 Syntex Corporation Dromostanolone propionate implant pellet useful for producing weight gains in animals and suppressing estrus in female animals
SU573159A1 (ru) 1976-03-17 1977-09-25 Всесоюзный Ордена Трудового Красного Знамени Научно-Исследовательский Институт Животноводства Способ синхронизации охоты и овул ции у свиноматок
US4732763A (en) 1978-10-17 1988-03-22 Stolle Research And Development Corporation Active/passive immunization of the internal female reproductive organs
US4756907A (en) 1978-10-17 1988-07-12 Stolle Research & Development Corp. Active/passive immunization of the internal female reproductive organs
JPS5781447A (en) 1980-11-11 1982-05-21 Toyo Jozo Co Ltd Human chorionic gonadotropic hormone c-terminal fragment
GB8428201D0 (en) 1984-11-08 1984-12-19 Glaxo Group Ltd Biological preparations
US4931279A (en) 1985-08-16 1990-06-05 Bausch & Lomb Incorporated Sustained release formulation containing an ion-exchange resin
US4804626A (en) 1986-10-22 1989-02-14 The General Hospital Corporation Immunometric assay for the detection of human chorionic gonadotropin
US4780451B1 (en) 1987-01-23 1995-04-04 Asua International Inc Composition and method for producing superovulation in cattle
US5276022A (en) 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
DE68907066T2 (de) 1988-01-29 1993-12-16 Koken Kk Verbesserte Formulierungen mit kontrollierter Abgabe.
US4975280A (en) 1989-01-23 1990-12-04 Ethyl Corporation Bioerodable sustained release implants
FR2663223B1 (fr) 1990-06-14 1994-12-02 Af Aplicaciones Far Lab Forme galenique parenterale.
US5180711A (en) 1990-06-14 1993-01-19 Applied Research Systems Ars Holding N.V. Combined treatment with gnrh antagonist and gnrh to control gonadotropin levels in mammals
US5434136A (en) 1990-12-14 1995-07-18 Mathias; John R. Treatment of motility disorders with a GNRH analog
IE62665B1 (en) 1990-12-17 1995-02-22 Akzo Nv Contraceptive regimen
HU222501B1 (hu) 1991-06-28 2003-07-28 Endorecherche Inc. MPA-t vagy MGA-t tartalmazó nyújtott hatóanyag-felszabadulású gyógyászati készítmény és eljárás előállítására
US5444167A (en) 1993-07-07 1995-08-22 Wallac Oy Variant luteinizing hormone encoding DNA
ATE183926T1 (de) 1993-09-29 1999-09-15 Alza Corp Hautpermeabilitaetserhöher bestehend aus monoglycerid/laktat estern
US5650173A (en) 1993-11-19 1997-07-22 Alkermes Controlled Therapeutics Inc. Ii Preparation of biodegradable microparticles containing a biologically active agent
US5688506A (en) 1994-01-27 1997-11-18 Aphton Corp. Immunogens against gonadotropin releasing hormone
FR2717688B1 (fr) 1994-03-28 1996-07-05 Lhd Lab Hygiene Dietetique Système matriciel transdermique d'administration d'un oestrogène et/ou un progestatif à base d'EVA.
US5747058A (en) 1995-06-07 1998-05-05 Southern Biosystems, Inc. High viscosity liquid controlled delivery system
US5589457A (en) 1995-07-03 1996-12-31 Ausa International, Inc. Process for the synchronization of ovulation
GB9514816D0 (en) 1995-07-19 1995-09-20 Ucli Ltd Substances and their medical use
JP2000506165A (ja) 1996-03-04 2000-05-23 ザ ペン ステイト リサーチ ファウンデーション 細胞インターナリゼーションを増強するための物質および方法
FR2747042B1 (fr) 1996-04-05 1998-06-05 Besins Iscovesco Lab Medicament a base de progesterone et d'oestradiol
AU2827797A (en) 1996-05-30 1998-01-05 Sepracor, Inc. Nsaids for regulating the reproductive cycle of domesticated animals
US6051558A (en) 1997-05-28 2000-04-18 Southern Biosystems, Inc. Compositions suitable for controlled release of the hormone GnRH and its analogs
US6028057A (en) 1998-02-19 2000-02-22 Thorn Bioscience, Llc Regulation of estrus and ovulation in gilts
FR2776520B1 (fr) 1998-03-25 2000-05-05 Sod Conseils Rech Applic Nouvelles compositions pharmaceutiques destinees a la liberation prolongee de peptides et leur procede de preparation
US6087352A (en) 1998-08-17 2000-07-11 Trout; William E. Use of Zeranol to modulate reproductive cycles
MXPA01003483A (es) 1998-10-05 2002-09-18 Penn State Res Found Composiciones y metodos para mejorar la internalizacion celular mediada por el receptor.
AU5025300A (en) 1999-06-18 2001-01-09 Southern Biosystems, Inc. Compositions for controlled release of the hormone gnrh and its analogs
GB0117057D0 (en) 2001-07-12 2001-09-05 Ferring Bv Pharmaceutical composition
EP1610803B8 (en) 2003-03-04 2011-09-14 AspenBio Pharma, Inc. LH for use in maintaining one or more pregnancies by inducing accessory corpus luteum formation.
CA2523830A1 (en) * 2003-04-30 2004-11-11 Debiopharm S.A. Methods and compositions using gonadotropin hormone releasing hormone
US7456207B2 (en) 2003-09-25 2008-11-25 Teva Pharmaceuticals Usa, Inc. Vaginal pharmaceutical compositions and methods for preparing them
WO2005035717A2 (en) 2003-10-03 2005-04-21 Thorn Bioscience, Llc Process for the synchronization of ovulation for timed breeding without heat detection
FR2865938B1 (fr) 2004-02-05 2006-06-02 Sod Conseils Rech Applic Formulation retard solide comprenant de l'acetate de triptoreline
AU2006307604B2 (en) 2005-10-24 2014-05-01 Manawatu Diagnostics Limited Ovulation cycle monitoring and management
US20090036384A1 (en) 2005-12-02 2009-02-05 Parnell Laboratories (Aust) Pty Limited Increasing pregnancy rates
US20070197435A1 (en) 2006-02-17 2007-08-23 Webel Stephen K Process for the synchronization of ovulation for timed breeding without heat detection
EP1891941A1 (en) 2006-08-11 2008-02-27 OctoPlus Technologies B.V. Aqueous gels comprising microspheres
EP2065032A1 (en) 2007-11-27 2009-06-03 Galderma Research & Development A method for producing adapalene gels
CN102596215B (zh) 2009-04-23 2015-04-29 佩纳特克有限责任公司 用于同步授精时间的方法和组合物
CN104136013A (zh) 2012-02-08 2014-11-05 道康宁公司 用于递送保健活性剂的有机硅乳液
ES2808409T3 (es) 2012-11-28 2021-02-26 United Ah Ii Llc Método para sincronizar el tiempo de inseminación en cerdas primerizas
US20160375090A1 (en) 2013-11-27 2016-12-29 Jbs United Animal Health Ii Llc Method and composition for synchronizing time of insemination in gilts
TW201625218A (zh) 2014-04-18 2016-07-16 Ｊｂｓ聯合動物保健有限責任公司 製造含ｇｎｒｈ凝膠之方法

Also Published As

Publication number Publication date
ZA201504552B (en) 2017-11-29
EP2925339B1 (en) 2020-04-29
BR112015012453A2 (pt) 2017-07-11
CA2892762A1 (en) 2014-06-05
EP2925339A4 (en) 2016-08-03
US10376558B2 (en) 2019-08-13
US9724380B2 (en) 2017-08-08
US20180133283A1 (en) 2018-05-17
ES2808409T3 (es) 2021-02-26
CA2892762C (en) 2022-07-19
EP2925339A1 (en) 2015-10-07
CL2015001448A1 (es) 2016-01-04
DK2925339T3 (da) 2020-07-20
JP2016508030A (ja) 2016-03-17
US20150306169A1 (en) 2015-10-29
CR20150282A (es) 2015-09-01
MX2015006618A (es) 2015-12-16
AU2013352054A1 (en) 2015-06-04
RU2015125549A (ru) 2017-01-11
CN104994865A (zh) 2015-10-21
CN113398243A (zh) 2021-09-17
PH12015501187A1 (en) 2015-08-10
MX367876B (es) 2019-09-10
KR20150095715A (ko) 2015-08-21
WO2014085674A1 (en) 2014-06-05

Similar Documents

Publication Publication Date Title
BR112015012453A8 (pt) métodos e usos para sincronizar o tempo de ovulação e de inseminação em uma leitoa
CL2017003258A1 (es) Nuevos derivados hidroxiéster, un proceso para su preparación y composiciones farmacéuticas que los contienen
UY35351A (es) Formulaciones acuosas estables de adalimumab
CL2015002164A1 (es) Formulación combinada de dos compuesos antivirales.
GT201400230A (es) Necleòsidos de espìrooxetano de uracilo
GT201500233A (es) Derivados de benzotiofeno y composiciones de los mismos como degradantes selectivos de los receptores de estrógeno
UY34697A (es) Métodos para preparar análogos de nucleótidos
GT201400297A (es) Nuevos derivados tienopirimidina, un proceso para su preparación y composiciones farmacéuticas que los contienen
MX2013008850A (es) Composiciones y metodos para tratar enfermedades cardiovasculares.
CL2017000984A1 (es) Reducción de la viscosidad de formulaciones farmacéuticas
MX2016007063A (es) Peptidos terapeuticos.
UY34332A (es) Composiciones y métodos para controlar malezas co mprendiendo un polinucleótido y agente de transfe rencia, y que modulan la fitoeno desaturasa?.
AR077199A1 (es) Composicion farmaceutica y procedimiento de tratamiento para la anticoncepcion de emergencia
CL2018001635A1 (es) Formulaciones y métodos para controlar el ciclo reproductivo y la ovulación.
BR112012024432A2 (pt) composição farmacêutica de dissolução rápida
AR091465A1 (es) Una composicion farmaceutica que contiene acido nicotinico y/o nicotinamida y/o triptofano para influenciar positivamente la microbiota intestinal
BR112016008576A2 (pt) Formulações aquosas estáveis de anticorpos e forma farmacêutica de dosagem unitária
BR112017017886A2 (pt) gerando populações de células endoteliais arteriais
BR112015030268A2 (pt) composição farmacêutica, recipiente, kit, e, método para a preparação de uma composição
BR112013015634B8 (pt) composição que compreende gordura, proteína e carboidratos, uso da composição, uso de fibras alimentares, processo para preparação de uma fórmula infantil e processo para preparação da composição
BR112014020113A8 (pt) Composições farmacêuticas e método para diminuir a frequência de micção
PH12015502589A1 (en) 4`-azido, 3`-deoxy-3`-fluoro substituted nucleoside derivatives
AR100028A1 (es) Composiciones nutricionales que contienen ácido estearidónico
MX373305B (es) Método para estabilizar una composición que contiene al menos un producto de deshidratación interna de un azúcar hidrogenado, composición resultante y usos de esta.
CL2011002651A1 (es) Composicion veterinaria que comprende dipropionato de imidocarb, cianocobalamina vitamina b12 y un vehiculo farmaceuticamente aceptable; y su uso para tratar o prevenir enfermedades infecciosas parasitarias en ganado.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B25D Requested change of name of applicant approved

Owner name: UNITED-AH II, LLC (US)

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]